01—Abstract
Summary
Summary of the 8-K filed August 8, 2024. Cited figures are marked; the original filing is the authoritative source.
Rocket Lab reported record second-quarter 2024 revenue of $106.3 milliona, up 71% from $62.0 million a year earlier, driven by growth in both Launch Services and Space Systems.
Net loss narrowed to $41.6 millionb from $45.9 million, and Adjusted EBITDA loss widened slightly to $21.2 million from $20.2 million. GAAP gross margin improved to about 25.6% from about 23.5%, and non-GAAP gross margin was 30.7%, down from 31.8% a year earlier. Operating expenses rose to $70.4 million, led by a 29% increase in research and development spending tied to the Neutron program.
The balance sheet strengthened materially during the period. Rocket Lab issued $355 millionc of convertible senior notes due to fund operations and repaid $45.8 million under its Trinity loan. Cash, cash equivalents and marketable securities totaled roughly $543 million at June 30, 2024, up from about $324 million at year-end 2023, and contract liabilities grew to $184 million, indicating strong forward bookings.
Management also reported more than $720 milliond in spacecraft under contract and 17 new launch contracts signed year-to-date. The third-quarter guidance is the key point for investors.
Revenue of $100 million to $105 million implies a sequential decline from Q2, and the company expects Adjusted EBITDA loss of $31 million to $33 million, wider than Q2's $21 million loss, with GAAP operating expenses of $80 million to $82 million. Investors will be focused on Neutron development milestones, the timing of the first Neutron flight, and whether the company can reach profitability as its Launch Services and Space Systems revenue scales.
02—Key points
Key Highlights
- Record quarterly revenue of $106.3 million, up 71% year-over-year from $62.0 million, with six-month revenue of $199.0 million, up 70%.
- Net loss narrowed to $41.6 million ($0.08 per share) from $45.9 million ($0.10 per share) a year earlier, helped by a $0.9 million income tax benefit.
- Adjusted EBITDA loss of $21.2 million versus $20.2 million in Q2 2023, while non-GAAP gross margin was 30.7%, down from 31.8%.
- Cash, cash equivalents and marketable securities of roughly $543 million at June 30, 2024, after issuing $355 million of convertible senior notes; convertible notes carried at $344.3 million net.
- Contract liabilities rose to $184.0 million from $139.3 million at year-end 2023, and more than $720 million in spacecraft under contract.
- Neutron milestone reached with the first Archimedes engine hot fire; 17 new launch contracts signed year-to-date.
- Q3 2024 guidance calls for revenue of $100 million to $105 million, a sequential decline, and an Adjusted EBITDA loss of $31 million to $33 million, wider than Q2.
03—Questions
Frequently Asked Questions
Why did Rocket Lab's revenue grow so strongly in Q2 2024?
Revenue reached $106.3 million, up 71% year-over-year, reflecting higher Electron launch activity for government and commercial customers and continued progress on spacecraft programs including NASA ESCAPADE, Varda, Space Development Agency and MDA/Globalstar constellations. Management cited Electron's share of non-SpaceX U.S. orbital launches in 2024 as evidence of demand.
Is Rocket Lab getting closer to profitability?
Not yet. The net loss narrowed modestly to $41.6 million from $45.9 million, but Adjusted EBITDA loss widened to $21.2 million from $20.2 million, and GAAP operating loss was $43.3 million. Operating expenses rose to $70.4 million, mainly from higher research and development spending on Neutron. Q3 guidance implies a wider Adjusted EBITDA loss of $31 million to $33 million.
Why does Q3 guidance point to lower revenue than Q2?
The company guided Q3 revenue to $100 million to $105 million, slightly below Q2's $106.3 million. Space Systems revenue is expected at $79 million to $84 million and Launch Services at about $21 million. The filing does not give a detailed explanation for the sequential decline, so investors should review the earnings call for management's reasoning on timing of launches and milestones.
How is Rocket Lab funding its operations and Neutron development?
In the first half of 2024, Rocket Lab issued $355 million of convertible senior notes, net of $43.2 million spent on capped calls and $12.2 million of debt issuance costs, and repaid $45.8 million on its Trinity loan. Operating cash use was $15.6 million for the six months, while investing outflows of $63.1 million included $34.5 million of capital expenditures. Cash and marketable securities of about $543 million provide a substantial cushion, although the company remains loss-making and the convertible notes add future dilution and repayment considerations.
What are the key risks and near-term catalysts for investors?
Key risks cited in the forward-looking statements include delays in the Neutron rocket, dependence on a limited number of customers, launch failures or schedule disruptions, supply chain issues and government funding or regulatory changes. Near-term catalysts include the first Archimedes engine production progress, Neutron launch infrastructure at Wallops, Virginia, the ESCAPADE Mars mission launch planned for 2024, and whether the company meets its Q3 revenue and loss guidance.
04—Continue